Vertex raises annual revenue forecast on cystic fibrosis drugs strength

Vertex Pharmaceuticals on Monday raised the upper end of its annual revenue forecast, banking on robust demand for its cystic ​fibrosis treatments.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。